Epibiotech Co., Ltd. (XKON:446440)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,000
-380 (-2.32%)
At close: Oct 2, 2025

Epibiotech Revenue

In the year 2022, Epibiotech had annual revenue of 449.62M KRW with 15.93% growth.

Revenue
449.62M
Revenue Growth
+15.93%
P/S Ratio
82.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
36.91B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2022449.62M61.77M15.93%
Dec 31, 2021387.85M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition